Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. World Health Organization. Global Tuberculosis Report 2016. http://www.who.int/tb/publications/global_report/en/ (2016) (Date of access:03/04/2017).
2. Uplekar, M. et al. WHO’s new End TB Strategy. The Lancet 385, 1799–1801, doi: 10.1016/S0140-6736(15)60570-0 (2015).
3. Rustomjee, R. et al. Key issues in the clinical development and implementation of TB vaccines in South Africa. Tuberculosis 92, 359–364, doi: 10.1016/j.tube.2012.05.001 (2012).
4. Garcia-Basteiro, A. L., Ruhwald, M. & Lange, C. Design of tuberculosis vaccine trials under financial constraints. Expert Rev Vaccines 15, 799–801, doi: 10.1080/14760584.2016.1178067 (2016).
5. Walzl, G., Ronacher, K., Hanekom, W., Scriba, T. J. & Zumla, A. Immunological biomarkers of tuberculosis. Nature reviews. Immunology 11, 343–354, doi: 10.1038/nri2960 (2011).
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献